With the advent of endovascular therapy and the increasing recognition of this entity, it is time to evaluate what truly is a May-Thurner syndrome (MTS).
As early as 1851, Virchow noted a striking five-fold left-sided preponderance for lower extremity deep venous thrombosis (DVT). It was not until the seminal cadaveric study by May and Thurner in 1957 that comprehensive description of the anatomy underlying this peculiarity was provided; namely, the compression of the left common iliac vein (LCIV) by the overlying right common iliac artery ( Figure 1 ). The authors postulated that venous 'spurs' arose through a combination of chronic mechanical compression and endothelial disruption from adjacent arterial pulsations. Thus, by fulfilling two elements of Virchow's triad, this entity represents an anatomical substrate for DVT.
MTS, or iliac vein compression, now encompasses a wider spectrum of pathology; rarer variants have been described, including compression of the right common iliac vein by the right common iliac artery. Clinical manifestation may be acute, with venous spur development and left lower limb DVT (disease classification stages II and III, respectively), or chronic, including unilateral limb swelling, venous claudication, varicose veins, and ulceration.
However, this anatomical anomaly may represent a subclinical phenomenon (stage I disease); evidence of LCIV obstruction has been identified in up to 30% of cadavers. Furthermore, in a review of 50 computed tomography (CT) scans performed in patients with abdominal pain, surprisingly, a quarter had at least 50% and two-thirds at least 25% LCIV compression. 1 The often silent nature of the lesion precludes accurate assessment of its true prevalence. Additionally, it may be overlooked in the investigation of left iliofemoral DVT and so under-diagnosed as an aetiological factor. A parallel may be drawn to the presence of isolated perforator disease in patients with superficial venous insufficiency; the clinical significance of treating these vessels is debated.
Nonetheless, MTS is clearly clinically relevant in both acute and chronic presentations. Iliac vein 'spurs' have been reported on intra-operative phlebography in 49% of patients presenting with left iliofemoral DVT 2 ; in a population of patients with left lower limb chronic venous disease (CVD), 14.8% had evidence of MTS. 3 Therefore, when does MTS become pathological rather than simply a silent anatomical variant? May and Thurner believed this syndrome to be an acquired phenomenon present in cadavers but absent in embryonic development.
This is an important question to address, as this syndrome is most frequently observed in healthy individuals, in the second to fourth decades, where it can translate into a source of significant morbidity and, potentially, mortality. 1 Regrettably, there is a paucity of high-level evidence upon which to base guidelines regarding the diagnosis of MTS. Studies are small, often retrospective, and employ a variety of imaging modalities. There is also little consensus regarding intervention in individuals with MTS who have not developed DVT or regarding the optimal management of CVD in this context.
Clinical presentations suggestive of MTS include left lower extremity DVT in the absence of differential causes of iliofemoral thrombosis and, more indolently, signs and symptoms of CVD not responding to conventional management. A retrospective study found that over 50% of patients with venous ulceration not responding to compression therapy or surgical intervention aiming to correct superficial reflux had evidence of iliac vein narrowing. 4 The bedrock of diagnosis remains within a plethora of imaging modalities including, duplex ultrasound (DUS), conventional venography, magnetic resonance venography (MRV), computed tomography venography (CTV) and intravascular ultrasound (IVUS). The first is often employed initially to assess lower limb venous anatomy; however, due to its limitations in assessing suprainguinal anatomy, a negative finding should not preclude further pelvic vein imaging in the context of unilateral leg swelling and pain. Indeed, MRV has revealed intra-luminal iliac spurs in patients with normal DUS. 5 It is important to remember, however, that these are anatomical investigations usually performed in the supine position and may not reflect haemodynamic characteristics exacerbated by the standing position.
A key shortcoming of numerous studies in the literature is the failure to ascertain what constitutes a significant narrowing; the threshold of 70% LCIV stenosis has been assessed by a number of authors.
Oguzkurt et al. performed a retrospective assessment of contrast-enhanced CT scans in 34 patients with venography-diagnosed MTS and left lower extremity DVT, compared to age-and sex-matched controls. 6 Interestingly, the MTS cohort reported compression percentages of 45-100%, compared to 0-68% in controls, i.e. a significant overlap with the critical 70% threshold. Importantly, almost one-third of the DVT cohort had vein compression of less than 70%, and would have therefore been missed by their proposed threshold.
A larger study of 239 CT scans in patients with unilateral DVT revealed that only 9.8% of patients met the 70% LCIV stenosis cut-off. 7 The above analyses were unadjusted for DVT risk factors, but both demonstrate the lack of consensus with respect to a significant stenosis.
The field is further clouded by studies failing to account for the apparent dynamic nature of LCIV compression, although there is evidence that isolated imaging is not sufficient to diagnose pathological MTS. A study of 36 patients with MRVconfirmed MTS found a 23% mean change in LCIV compression on CTV or MRV within six months (range: 12% decrease to 69% increase). 8 The likely factors underlying this anomaly are patient hydration status and positioning.
There are additional reasons to interpret pelvic vein imaging with caution. The literature is fraught with widespread disparity in quantitative means to assess LCIV compression with lack of a validated standard; standard venography can underestimate the magnitude of stenosis by 30% compared to IVUS. 9 Moreover, it is too simplistic to assume that there is a critical threshold of LCIV compression beyond which MTS has clinical sequelae. Rather, it is clear from the inconsistencies described that numerous factors combine to constitute pathological MTS. May and Thurner advocated the values of 2 mmHg at rest and 3 mmHg upon exercising as significant pressure gradients between the iliac veins. DUS has been identified as a sensitive method to identify venous stenosis; a peak vein velocity ratio of >2.5 across the narrowing in the presence of a 3 mmHg pressure gradient was defined as the best criterion and confirmed by invasive testing. 10 The existence of pelvic venous collaterals is a further clue for the presence of pathological MTS, suggestive of LCIV compression reaching haemodynamic significance.
Clearly identifying pathological MTS from normal variance is far from straightforward. MTS in its true sense describes persistent LCIV narrowing with evidence of haemodynamic compromise. This evidence may take a variety of forms; however, the use of a single stenosis threshold is unlikely to be helpful. A comprehensive answer awaits robust, adequately powered studies. Several hurdles to this aim exist, including deciphering the weight of a single pro-thrombotic factor, establishing the optimal diagnostic imaging protocol and the most appropriate management strategy.
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